Business Context and Reporting Period
This Form 8-K Current Report was filed by The Carlyle Group Inc. on March 3, 2021. The report discloses a corporate governance event: the appointment of a new member to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the appointment of Derica Rice to the Board of Directors, effective March 8, 2021. The appointment was approved by the Board on March 3, 2021. Mr. Rice will serve as a Class II director.
Management Commentary and Compensation
Mr. Rice brings significant executive experience, having previously served as Executive Vice President of CVS Health and President of CVS Caremark (2018–2020), and as Executive Vice President and CFO of Eli Lilly and Company (2006–2017). He currently serves on the boards of Bristol-Myers Squibb, Target Corporation, and The Walt Disney Company. No committee appointments have been made at this time. Mr. Rice will receive the standard annual compensation provided to non-employee directors as outlined in the Company's 2019 Form 10-K.
Investor Verification Checklist
- Verify the effective date of Mr. Rice's board appointment (March 8, 2021).
- Review the "Director Compensation" section of the 2019 Form 10-K to confirm the specific compensation package for non-employee directors.
- Monitor future filings for any committee assignments designated for Mr. Rice.
- Confirm that no other financial or operational metrics were disclosed in this specific 8-K filing.